Automated Author Profile

Sheng, Jifang

Zhejiang University

Current S-Index

0.8

Sum of Dataset Indices for all datasets

Average Dataset Index per Dataset

0.8

Average Dataset Index per dataset

Total Datasets

1

Total datasets for this author

Average FAIR Score

69.2%

Average FAIR Score per dataset

Total Citations

1

Total citations to the author's datasets

Total Mentions

0

Total mentions of the author's datasets

S-Index Interpretation

S-Index Over Time

Cumulative Citations Over Time

Cumulative Mentions Over Time

Datasets

The artificial-liver blood-purification system can effectively improve hypercytokinemia for COVID-19 (Version: 5)

Since December 2019, the outbreak of Coronary Virus Disease 2019 (COVID-19) occurred in Wuhan, and rapidly spread across the country, and the world. As the number of diagnoses and deaths continues to rise, this has become the focus of international public health. COVID-19 is highly contagious, and there is no effective treatment. New treatment strategies are urgently needed to improve the treatment success rate of severe and critically ill patients. Increasing evidence has shown that cytokine storm plays an important role in the progression of COVID-19. The artificial liver blood purification system (ALS) is expected to improve the cytokine storm. In the present study, the levels of cytokines and chemokines were detected in 12 COVID-19 patients before and after ALS, and exciting results were obtained. The present study has directly proven that ALS can block the cytokine storm, rapidly remove the inflammatory mediators, and hopefully suppress the progression of the disease, providing a new idea for the clinical treatment of COVID-19.

Authors

  • Guo, Jing ;
  • Xia, He ;
  • Wang, Shuting ;
  • Yu, Liang ;
  • Zhang, Huafen ;
  • Chen, Jun ;
  • Shi, Ding ;
  • Chen, Yanfei ;
  • Zhang, Yan ;
  • Xu, Xiaowei ;
  • Xu, Kaijin ;
  • Sheng, Jifang ;
  • Qiu, Yunqing ;
  • Li, Lanjuan
1 Citation0 Mentions69% FAIR0.8 Dataset Index
10.5061/dryad.f1vhhmgtq2021